Does Roflumilast Interact with Gestodene And Ethinyl Estradiol?
CDI records a moderate classification for Roflumilast and Gestodene And Ethinyl Estradiol. The stored summary is: Oral contraceptive combination that may increase roflumilast systemic exposure and result in increased side effects. Risk should be weighed against benefit. The mechanism involves increased roflumilast systemic exposure. Patients taking both medications should consult their healthcare provider before starting, stopping, or changing the dosage of either drug. This record was extracted from drug labeling through openFDA. NIH/NLM RxNorm is used for drug identities. The summary and severity classification are CDI's processed information, not a verbatim source quotation. Product, route, and patient circumstances matter.
- Severity
- Moderate
- Roflumilast Class
- Phosphodiesterase 4 Inhibitor
- Management
- Monitor for effects
- Data Source
- U.S. FDA via OpenFDA
Recorded Mechanism
Increased roflumilast systemic exposure
What To Tell Your Doctor or Pharmacist
If you are taking Roflumilast and your doctor is considering prescribing Gestodene And Ethinyl Estradiol (or vice versa), make sure to:
- Inform your doctor and pharmacist of all current medications, including over-the-counter drugs and supplements
- Ask whether the benefits of combining these medications outweigh the risks for your specific situation
- Ask what symptoms to watch for that would indicate the interaction is causing problems
- Ask whether any dosage adjustments are needed
- Never stop or change either medication without first consulting your healthcare provider